E-mail:BD@ebraincase.com
Tel:+8618971215294
English 中文版
Virus Vector - Viral Vector Production - BrainCaseVirus Vector - Viral Vector Production - BrainCase
  • Home
  • Virus product library
    CRISPRRNAiHSV-helperRV-helperNeurophilic virusCalcium SensorsOptogenetics activationOptogenetics inhibitionChemical geneticsSparse labelingFluorescent proteinBiosensorsRecombinaseApoptosis & AutophagyDisease ModelNeurotoxicityOther
  • Products & Service

    Product Center

    Virus

    VSV-circuit research-vaccine and gene therapy research-BrainCase
    Retrovirus-RCAS-TVA-BrainCase
    Lentivirus Vector - Lentivirus Production - BrainCase
    Rabies Virus Vector - RBV Vector - BrainCase
    Herpes simplex virus-Oncolytic and anterograde tracing-Brain Case
    PRV-retrograd multisynaptic-Peripheral-Btain Case
    AAV-gene therapy vectors-BrainCase

    Animal Model

    Neurological Disease Models-BrainCase
    Tumor animal models-anti-tumor-BrainCase
    Digestive System Disease Animal Model-Brain Case
    Cardiovascular System Disease Animal Models-Brain Case

    Plasmid Construction

    Library Construction
    Plasmid design and construction

    Popular Applications

    Gene Regulation

    Gene Overexpression-Brain Case
    RNA interference(RNAi)-siRNA-Brain Case
    Gene Editing - CRSIPR cloning - BrainCase

    Neural Circuit Function Research

    Optogenetics - BrainCase
    Chemical genetics-DREADDs-Brain Case
    Calcium signal recording-Gels- Brain Case
    GRAB Neurotransmitter Fluorescent Probe- Brain Case
    Functional Magnetic Resonance Imaging Technology- Brain Case

    Research on the structure of neural circuits

    Direct Input and Output-viral vectors- Brain Case
    Anterograde Mono-synaptic Tracing -HSV- Brain Case
    Antrograde Muti-synaptic Tracing-HSV & VSV-Brain Case
    Retrograde Mono-synaptic Tracing-Rabies Virus-Brain Case
    Retrograde Muti-synaptic Tracing-PRV-Brain Case

    Featured Services

    Nervous System Disease Drug Effect

    Alzheimer's disease-AD-Brain Case
    Depression-mental disorders-Brain Case
    Parkinson's disease--PD-Brain Case
    Epilepsy-an ancient neurological disorder-Brain Case

    AAV Serotype Screening

    AAV Serotypes screening-gene therapy-Brain Case

    Tumorigenicity Test

    Tumorigenicity Testing-Evaluation of tumor models-Brain Case

    Efficacy of Oncolytic Virus

    Oncolytic virus-for cancer therapy-Brain Case
    Herpes Virus Vector-anti-tumor- BrainCase
    Vesicular stomatitis virus-killing tumor cells-Brain Case
  • News
    Corporate News New Product Launch Media Activity Investor News
  • Support
    Literature interpretation Customer article Video Zone FAQs
  • About Us
  • Contact
    Contact UsJoin us
  • 中文
    English 中文版
  • Home
  • Support
  • Literature interpretation
  • Support
  • Literature interpretation
  • Customer article
  • Video Zone
  • FAQs

Cre-loxP & Flp-FRT system | Everything you want to know about recombinase is here

Release time:2025-04-10 10:12:43

What are Cre and loxP?

In 1981, Nat Sternberg et al. reported a protein cloned from the P1 bacteriophage of Escherichia coli—a 38 kDa recombinase encoded by 343 amino acids called Cre (Cyclization Recombination Enzyme). It specifically recognizes loxP sites and mediates sequence deletion or recombination between loxP sites. The loxP (locus of X-overP1) site is 34 bp long, consisting of two 13 bp inverted repeat sequences and an 8 bp spacer region. The inverted repeat sequences are the specific recognition sites for the Cre recombinase, while the spacer region determines the orientation of loxP.

The Cre-loxP system induces gene recombination in several ways

The result of DNA recombination depends on the direction and position of the two loxP sites, primarily leading to the following types of recombination:

A. Deletion: When two loxP sites are on the same DNA strand and oriented in the same direction, the Cre recombinase excises the sequence between the loxP sites.
B. Inversion: When two loxP sites are on the same DNA strand and oriented in opposite directions, the Cre recombinase inverts the sequence between the loxP sites.
C. Translocation: When two loxP sites are on different DNA strands or chromosomes, the Cre recombinase induces an exchange between the DNA strands or a chromosomal translocation.

Classification of the Cre-loxP system

1. LSL Sequence (Cre-on)

Based on the above principles, the LSL sequence (loxP-STOP-loxP) was designed. In the absence of Cre recombinase, the downstream gene cannot be normally expressed due to the presence of the STOP cassette. Upon introduction of Cre recombinase, the STOP sequence is deleted, allowing the downstream gene to be expressed normally, thereby achieving Cre-dependent gene expression.

2. FLEX/DIO Sequence (Cre-on)

However, in practical applications, it was found that LSL could still lead to slight expression of the downstream gene even in the absence of Cre recombinase. In 2003, Frank Schnütgen et al. developed FLEX (Flip-excision) and, based on this, DIO (Double-Floxed Inverted Open reading frame), which changes the orientation of loxP and lox2272, greatly mitigating the leakage issue. lox2272 is also a commonly used lox site, similar to loxN, lox511, etc. lox2272 and loxP are mutually incompatible and are respectively targeted by Cre recombinase. In the DIO structure, Cre recombinase causes one inversion and one deletion through loxP and lox2272, thus achieving irreversible inversion and Cre-dependent expression of the target gene.

3. DO Sequence (Cre-off)

The inserted gene is oriented in the same direction as the promoter. In the presence of Cre recombinase, recombination occurs, causing the gene to invert and thus preventing normal expression.

4. CIAO Sequence (Cre-on)

Given the leakage expression issues with both LSL and DIO/FLEX, the Edward M. Callaway team designed a CIAO (cross-over insensitive ATG-Out) sequence, which almost eliminates the leakage problem. CIAO uses the ATG-OUT construction method, placing the ATG and the ORF of the target gene on opposite sides of the lox sequence. This means that if recombination does not occur, the target gene is incomplete, and even if transcription of the gene occurs, no functional protein will be translated. Additionally, the non-symmetrical lox66/71 sequences are used to further reduce spontaneous recombination during plasmid replication in bacteria. However, compared to loxP and lox2272, the recombination efficiency of Cre recombinase with lox66/71 is also reduced.


 

Application of the Cre-loxP system

Why use viruses in addition to breeding two strains of mice?

This is because using viruses to achieve target gene overexpression (OE) or knockdown (KD) often results in a shorter experimental period and lower experimental costs compared to mouse breeding. Additionally, OE/KD resulting from mouse breeding is generally systemic, whereas viruses can more easily achieve gene regulation in local tissues or specific organs, allowing for more detailed studies.

# Cre mice x Floxed mice Cre mice x DIO Virus Floxed mice x Cre Virus
CKO One of the most commonly used and stable methods for gene knockout Injecting AAV (carrying ShRNA or SgRNA/Cas9) into Cre mice can achieve local or systemic knockout Injecting AAV-Cre into floxed mice can achieve local or systemic knockout
CKI Commonly used reporter mice include mT/mG, Ai9, Ai14, etc Injecting AAV-DIO-GOI into Cre mice can achieve local or systemic overexpression Specific cell labeling can be achieved by injecting Cre virus into reporter mice

Different versions of Cre

1. iCre

iCre improves expression and activity in mammalian cells by optimizing Cre codons for mammalian preferences.

2. CreER

CreER is a fusion protein of Cre recombinase and the estrogen receptor (ER). Without an inducer, the expressed CreER binds to HSP90 protein and is localized in the cytoplasm, preventing it from entering the nucleus to edit genomic DNA. Only when an inducer (Tamoxifen or 4-OHT) is added, the inducer binds to the CreER protein, causing a conformational change that releases CreER from the anchoring protein HSP90. This allows CreER to enter the nucleus, recognize loxP sites, and induce recombination. By controlling the timing of inducer injection, temporal specificity of gene recombination can be achieved.

3. CreERT2

To avoid interference from endogenous estrogen, a point mutation (G521R) was introduced in the ligand-binding domain of the estrogen receptor, resulting in CreERT, which responds only to synthetic exogenous estrogens (Tamoxifen or 4-OHT). CreERT2 is a further improved version of CreERT, containing three additional point mutations (C400V/M453A/L544A), making it more sensitive and faster in response to Tamoxifen.

4. Split-Cre

The Split-Cre system divides Cre recombinase into two inactive parts (CreN and CreC), each controlled by different induction conditions. Cre recombinase is only activated and functional when both parts are present and combined. The IBIST system follows a similar principle.

5. Light-activated Cre

Light-activated Cre (light-inducible Cre) is a type of Cre recombinase that is activated by light. Typically, a light-sensitive protein is fused with Cre, and under specific wavelengths of light, the light-sensitive protein changes its conformation, thereby activating Cre.

Various Recombinase Systems

In the face of increasingly refined research, Cre recombinase no longer meets all needs. The development of other recombinase systems continues to emerge.

1. Flp-FRT System

In 1985, Xu-Dong Zhu et al. reported the FLP recombinase derived from Saccharomyces cerevisiae. It is a monomeric protein composed of 423 amino acids that specifically recognizes the FRT (Flp recognition target) site. The FRT site is very similar to the loxP site, consisting of two 13 bp inverted repeat sequences and an 8 bp spacer sequence, with the spacer sequence determining the orientation of the FRT site. The recombination mechanism of the Flp-FRT system is similar to that of the Cre-loxP system.

2. Dre-Rox System

Many studies have shown the significant recombination efficiency of Cre recombinase, whereas Flp recombinase efficiency is much lower. Buchholz F et al. found that the optimal temperature for Cre recombinase is 37°C, while for Flp recombinase it is 30°C. Although Raymond CS developed a mutant Flp recombinase, Flpo, with thermal stability, narrowing the gap with Cre recombinase, it still falls short of expectations.
Therefore, in 2009, Brian Sauer et al. cloned the Dre recombinase from the D6 bacteriophage, which can effectively recognize the Rox sequence and mediate DNA recombination. The Rox sequence has a similar function and structure to the loxP sequence but with slight differences; the Rox sequence consists of two 14 bp inverted repeat sequences and a 4 bp spacer sequence. Additionally, the Cre-loxP and Dre-Rox systems are mutually exclusive, allowing them to be used simultaneously.

3. VCre-VloxP and SCre-SloxP Systems

The development of the Dre system has solved some issues, but the Rox site lacks corresponding mutants, limiting its applications. In 2011, Emiko Suzuki and Manabu Nakayama screened VCre and SCre from Cre recombinase homologs and constructed VloxP/Vlox2272 and SloxP/Slox2272 for them. The VCre/VloxP and SCre/SloxP systems have lower homology with the Cre/loxP system and do not interfere with each other, allowing for combined use.

4. ΦC31/pSIO System

In 2023, Byung Kook Lim's team designed the ΦC31/pSIO system and Bxb1/bSIO system based on the previously reported φC31 and Bxb1, and their specific recognition sites attB, attP, and attL, attR. The ΦC31/pSIO system can also target specific cell types without cross-reacting with Cre and Flp recombinases, further enriching the toolbox of recombinases.

Cross-usage of different recombinase systems

1. Sparse Labeling

By controlling the mixing ratio of AAV-DIO-Flp and AAV-FDIO-EYFP, the number of neurons can be controlled to achieve sparse and highly bright labeling. The team led by Xu Fuqiang at the Shenzhen Institute of Advanced Technology.

They further optimized this method by adopting a cocktail packaging strategy, co-packaging pAAV-DIO-Flp and pAAV-FDIO-EYFP together, which reduced the issue of mutual exclusion during mixed co-infection of different batches of viruses.

2. Boolean Logic System/INTRSECT

Using Boolean logic principles to modify and synthesize AAV vectors forms a Cre and Flp dual-recombinase cascade control system. This technology overcomes the limitation of single recombinase control systems, which can only study the function and circuit structure of a specific type of neuron. It enables further classification and subclass labeling of specific neurons, offering more selectivity.

3. cTRIO

In the cTRIO system, by injecting the retrograde tracer CAV2-DIO-Flp (now more often using the more efficient AAV2-retro-DIO-Flp) into brain area C, neurons in the B→C circuit carry Flp recombinase. This allows for the expression of previously injected AAV-FDIO-TVA-GFP and AAV-FDIO-RVG in brain area B. Finally, by injecting RV-EnvA-ΔG-mCherry, retrograde labeling to the cell bodies in upstream brain areas is achieved, thus marking the A→B→C three-level circuit in Cre mice.



 

If you are interested in the details of the experiment or possible problems and causes during the experiment, please contact: BD@ebraincase.com


💥Holiday

Special

Offers

Click to fill in the requirements and submit them to us!

Service Type :

Select the service you'd like to purchase.

Order Information(Premade-AAVs)

Please provide us some information about the service you'd like to order.

Detailed requirements:

scroll

Order Information(Custom AAV/Lentivirus)

Please provide us some information about the service you'd like to order.

Gene ID or gene information:

Selection of the reporting gene:

Special Instructions:

scroll

Order Information(Others)

Please provide us some information about the service you'd like to order.

Virus name/Detailed requirements:

scroll

Related products

Literature Interpretation | Nature | How to Detect Glial Phagocytosis of Synapses

Literature Interpretation | Nature | How to Detect Glial Phagocytosis of Synapses

Breaking Tool | Cell | Allen Institute for Brain Science Releases Over 1,000 Cortical Cell Targeting Tools, Marking a New Breakthrough in Decoding Brain Function!

Breaking Tool | Cell | Allen Institute for Brain Science Releases Over 1,000 Cortical Cell Targeting Tools, Marking a New Breakthrough in Decoding Brain Function!

IF=85 Cutting-edge Review | CRISPR’s Three-Dimensional Breakthrough: A Comprehensive Overview of Genome, Epigenome, and Transcriptome Editing

IF=85 Cutting-edge Review | CRISPR’s Three-Dimensional Breakthrough: A Comprehensive Overview of Genome, Epigenome, and Transcriptome Editing

Jing Wang, Zhaofa Wu, and Yulong Li’s research teams develop a novel probe to analyze the spatiotemporal dynamics and regulatory mechanisms of intracellular adenosine in vivo.

Jing Wang, Zhaofa Wu, and Yulong Li’s research teams develop a novel probe to analyze the spatiotemporal dynamics and regulatory mechanisms of intracellular adenosine in vivo.

map
{dede:global.cfg_webname/}

Virus product library

CRISPR
RNAi
Neurophilic virus
Optogenetics activation
Biosensors

News

Corporate News
New Product Launch
Media Activity
Investor News

Support

Literature interpretation
Customer article
Video Zone
FAQs
微信

WhatsApp Business Account

Tel: +8618971215294
E-mail: BD@ebraincase.com

Address:-

Address:-

  • Copyright © 2024 Brain Case All Rights Reserved.